Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSD | P07339 | 1/20 | 0.43 |
| ▸ | CA1 | P00915 | 2/20 | 0.43 |
| ▸ | CA2 | P00918 | 2/20 | 0.43 |
| ▸ | CA12 | O43570 | 1/20 | 0.43 |
| ▸ | CA4 | P22748 | 1/20 | 0.43 |
| ▸ | CA7 | P43166 | 1/20 | 0.43 |
| ▸ | CA9 | Q16790 | 1/20 | 0.43 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.43 |
| ▸ | PKM | P14618 | 2/20 | 0.42 |
| ▸ | MAPT | P10636 | 2/20 | 0.42 |
| ▸ | GABRA1 | P14867 | 1/20 | 0.42 |
| ▸ | GABRB1 | P18505 | 1/20 | 0.42 |
| ▸ | GABRG2 | P18507 | 1/20 | 0.42 |
| ▸ | GABRB3 | P28472 | 1/20 | 0.42 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.42 |
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.42 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8527732 | 0.85 | CTSD (0.43) | CTSDCA1CA2CA12CA4 | |
| SCHEMBL5180341 | 0.80 | CTSD (0.46) | CTSDCA1CA2CA12CA4 | |
| SCHEMBL7792874 | 0.78 | LMNA (0.49) | CTSDCA1CA2CA12CA9 | |
| SCHEMBL2770115 | 0.78 | CA1 (0.52) | CTSDCA1CA2CA12CA4 | |
| SCHEMBL2767752 | 0.78 | KDM4E (0.48) | CTSDCA1CA2CA12CA4 | |
| SCHEMBL4543403 | 0.77 | CTSD (0.47) | CTSDMAPTSTAT3TP53TSHR | |
| SCHEMBL5599369 | 0.76 | KDM4E (0.36) | MAPTGABRA1GABRB1GABRG2GABRB3 | |
| SCHEMBL11357634 | 0.76 | KDM4E (0.46) | CTSDCA1CA2CA12CA4 | |
| SCHEMBL9831434 | 0.76 | CTSD (0.53) | CTSDPKMMAPTKDM4EKMT2A | |
| SCHEMBL27607926 | 0.76 | CA1 (0.44) | CTSDCA1CA2CA12CA4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9951020-B2 | Methods of making 2-halonicotinonitriles | VIRGINIA COMMONWEALTH UNIVERSITY (US) | 2018-04-24 | — | — | US | disclosed |
| US-9951020-B2 | Methods of making 2-halonicotinonitriles | VIRGINIA COMMONWEALTH UNIVERSITY (US) | 2018-04-24 | — | — | US | disclosed |
| US-20160221951-A1 | METHODS OF MAKING 2-HALONICOTINONITRILES | VIRGINIA COMMONWEALTH UNIVERSITY | 2016-08-04 | — | — | US | disclosed |
| US-20160221951-A1 | METHODS OF MAKING 2-HALONICOTINONITRILES | VIRGINIA COMMONWEALTH UNIVERSITY | 2016-08-04 | — | — | US | disclosed |
| WO-2015031718-A1 | METHODS OF MAKING 2-HALONICOTINONITRILES | MCQUADE D TYLER (US) | 2015-03-05 | — | — | WO | disclosed |
| CN-1177848-C | Bicyclic heteroaromatic compounds useful as LH agonists | ��˹��ŵ�� | 2004-12-01 | — | — | CN | disclosed |
| CN-1349535-A | Bicyclic heteroaromatic compounds useful as LH agonists | AKZO NOBEL NV (NL) | 2002-05-15 | — | — | CN | disclosed |
| US-5541187-A | HYPOTENSIVE AGENTS | STERLING WINTHROP INC. (US) | 1996-07-30 | — | — | US | disclosed |
| US-5294612-A | Hypotensive agents and cardiovascular disorders | STERLING WINTHROP INC. (US) | 1994-03-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160221951-A1 | METHODS OF MAKING 2-HALONICOTINONITRILES | NISCH, HCN2, HCN1 | CTSD 4257/4885CA1 1267/4885CA2 1113/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.